Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
This slide presentation is the second part of a lecture I gave at the Seattle-based non-profit Cancer Lifeline a few months ago. This covers the evidence supporting post-operative (adjuvant) chemotherapy for patients with early stage NSCLC, the need to recognize that this does not apply to all patients who have undergone surgery, and the emerging clinical research and ongoing trials that may lead to improvements in our cure rate for early stage NSCLC patients in the future.
Here is the presentation in video format, the audio version, transcript, and a pdf file of the figures. I hope it's helpful.
[powerpress]
Cancer Lifeline Part 2 Adjuvant Therapy Early Stage NSCLC Audio Podcast
cancer-lifeline-part-2-adjuvant-therapy-early-stage-nsclc-transcript
cancer-lifeline-part-2-adjuvant-therapy-early-stage-nsclc-figures
Please feel free to offer comments and raise questions in our
discussion forums.
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
Here's the webinar on YouTube. It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Hi app.92, Welcome to Grace. I'm sorry this is late getting to you. And more sorry your mum is going through this. It's possible this isn't a pancoast tumor even though...